Moderna
MRNA
#1944
Rank
โ‚น894.91 B
Marketcap
โ‚น2,290
Share price
1.27%
Change (1 day)
-35.05%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚น894.91 Billion

As of December 2025 Moderna has a market cap of โ‚น894.91 Billion. This makes Moderna the world's 1944th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น894.91 B-32.45%
2024โ‚น1.324 T-58.03%
2023โ‚น3.156 T-44.72%
2022โ‚น5.710 T-25.5%
2021โ‚น7.664 T153.51%
2020โ‚น3.023 T544.07%
2019โ‚น469.41 B33.71%
2018โ‚น351.06 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Moderna was reported to be:

โ‚น894.79 Billion
by Nasdaq info icon info icon
โ‚น894.91 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
โ‚น50.76 B-94.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น22.643 T 2,430.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น74.86 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น5.523 T 517.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น22.832 T 2,451.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
โ‚น803.26 B-10.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น43.833 T 4,798.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น267.55 B-70.10%๐Ÿ‡บ๐Ÿ‡ธ USA